| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=10uM, 4-(2-Acetyl-5-ethyl-7,7,10,10-tetramethyl-8,9-dihydronaphtho[2,3-b][1,5]benzodiazepin-12-yl)-3-fluorobenzoic acid, Retinoid RXR Antagonists targeting RXRA (Novartis, 44427077) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/44427077 |
| Similar Terms | |
| Downloads & Tools |
5 genes differentially expressed following the BA-46-QO78_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| MT1E | metallothionein 1E | 2.04131 |
| MT2A | metallothionein 2A | 1.50981 |
| RPL12 | ribosomal protein L12 | 0.354105 |
| APRT | adenine phosphoribosyltransferase | 0.275565 |
| Symbol | Name | Standardized Value |
|---|---|---|
| SREBF1 | sterol regulatory element binding transcription factor 1 | -0.354105 |